Requirement of T-lymphokine-activated killer cell-originated protein kinase for TRAIL resistance of human HeLa cervical cancer cells

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 830-834

  Kwon, Hyeok Ran ^a   Lee, Ki Won ^b   Dong, Zigang ^c   Lee, Kyung Bok ^a   Oh, Sang Muk ^a  

^a Konyang University   (South Korea)

^b Konkuk University   (South Korea)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Apoptosis; Caspase; NF B; TOPK; TRAIL

Indexed keywords

CASPASE 3; CASPASE 8; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; PROTEIN KINASE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER THERAPY; CONTROLLED STUDY; GENE; HELA CELL; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX CANCER;

APOPTOSIS; CASPASE 3; CASPASE 8; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEOPLASMS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 72949103691     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.147     Document Type: Article

References (24)

1. Ashkenazi A., and Herbst R.S. To kill a tumor cell: the potential of proapoptotic receptor agonists. J. Clin. Invest. 118 (2008) 1979-1990
2. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., and Dixit V.M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85 (1996) 817-827
3. Wilson M.R. Apoptosis: unmasking the executioner. Cell Death Differ. 5 (1998) 646-652
4. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., and Goodwin R.G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673-682
5. Cotter T.G. Apoptosis and cancer: the genesis of a research field. Nat. Rev. Cancer 9 (2009) 501-507
6. Tamagiku Y., Sonoda Y., Kunisawa M., Ichikawa D., Murakami Y., Aizu-Yokota E., and Kasahara T. Down-regulation of procaspase-8 expression by focal adhesion kinase protects HL-60 cells from TRAIL-induced apoptosis. Biochem. Biophys. Res. Commun. 323 (2004) 445-452
7. Gaudet S., Branton D., and Lue R.A. Characterization of PDZ-binding kinase, a mitotic kinase. Proc. Natl. Acad. Sci. USA 97 (2000) 5167-5172
8. Abe Y., Matsumoto S., Kito K., and Ueda N. Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J. Biol. Chem. 275 (2000) 21525-21531
9. Dougherty J.D., Garcia A.D., Nakano I., Livingstone M., Norris B., Polakiewicz R., Wexler E.M., Sofroniew M.V., Kornblum H.I., and Geschwind D.H. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase. J. Neurosci. 25 (2005) 10773-10785
10. Abe Y., Takeuchi T., Kagawa-Miki L., Ueda N., Shigemoto K., Yasukawa M., and Kito K. A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis. J. Mol. Biol. 370 (2007) 231-245
11. Park J.H., Lin M.L., Nishidate T., Nakamura Y., and Katagiri T. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Cancer Res. 66 (2006) 9186-9195
12. Zhu F., Zykova T.A., Kang B.S., Wang Z., Ebeling M.C., Abe Y., Ma W.Y., Bode A.M., and Dong Z. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells. Gastroenterology 133 (2007) 219-231
13. Oh S.M., Zhu F., Cho Y.Y., Lee K.W., Kang B.S., Kim H.G., Zykova T., Bode A.M., and Dong Z. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation. Cancer Res. 67 (2007) 5186-5194
14. Zykova T.A., Zhu F., Lu C., Higgins L., Tatsumi Y., Abe Y., Bode A.M., and Dong Z. Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells. Clin. Cancer Res. 12 (2006) 6884-6893
15. Wu G.S. TRAIL as a target in anti-cancer therapy. Cancer Lett. 285 (2009) 1-5
16. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
17. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., and Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91 (1997) 243-252
18. Williams A.C., Smartt H., AM H.Z., Macfarlane M., Paraskeva C., and Collard T.J. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ. 14 (2007) 137-145
19. Ricci M.S., Kim S.H., Ogi K., Plastaras J.P., Ling J., Wang W., Jin Z., Liu Y.Y., Dicker D.T., Chiao P.J., Flaherty K.T., Smith C.D., and El-Deiry W.S. Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death. Cancer Cell 12 (2007) 66-80
20. Harper N., Farrow S.N., Kaptein A., Cohen G.M., and MacFarlane M. Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-kappa B activation by inhibition of apical caspases. J. Biol. Chem. 276 (2001) 34743-34752
21. Jeremias I., Kupatt C., Baumann B., Herr I., Wirth T., and Debatin K.M. Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood 91 (1998) 4624-4631
22. Franco A.V., Zhang X.D., Van Berkel E., Sanders J.E., Zhang X.Y., Thomas W.D., Nguyen T., and Hersey P. The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells. J. Immunol. 166 (2001) 5337-5345
23. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., and Baldwin Jr. A.S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281 (1998) 1680-1683
24. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schroter M., Burns K., Mattmann C., Rimoldi D., French L.E., and Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 388 (1997) 190-195